ChemicalBook > Product Catalog >API >Circulatory system drugs >Antihypertensive drugs >guanethidine

guanethidine

guanethidine Structure
CAS No.
55-65-2
Chemical Name:
guanethidine
Synonyms
Dopom;C07036;Eutensol;Abapresin;Octatensine;guanethidine;guanethidine USP/EP/BP;2-[2-(azocan-1-yl)ethyl]guanidine;1-(2-perhydroazocin-1-ylethyl)guanidine;N-[2-(Octahydroazocin-1-yl)ethyl]guanidine
CBNumber:
CB8875413
Molecular Formula:
C10H22N4
Molecular Weight:
198.31
MOL File:
55-65-2.mol
MSDS File:
SDS
Modify Date:
2023/5/21 10:59:17

guanethidine Properties

Boiling point 325.64°C (rough estimate)
Density 0.9402 (rough estimate)
refractive index 1.4910 (estimate)
storage temp. Store at -20°C
pka pKa 11.4 (Uncertain)

SAFETY

Risk and Safety Statements

Toxicity LD50 oral in rat: 1050mg/kg

guanethidine Chemical Properties,Uses,Production

Description

Guanethidine is used for severe hypertension when the use of the more generally accepted drugs turns out to be unsuccessful. It is a powerful, long-lasting antihypertensive drug; however, it affects a patient’s blood pressure only in the orthostatic position, and not when lying down.
Guanethidine is a very powerful and long-lasting drug, and its action often lasts 2–3 days after its use has been stopped.

Uses

Antihypertensive.

Uses

Guanethidine is used for severe hypertension, where use of more universally accepted drugs is not successful. It is a very powerful and long-lasting drug, and its effects last for 2–3 days after using it.

Definition

ChEBI: A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.

Biological Functions

Guanethidine (Ismelin) is a powerful antihypertensive agent that is quite effective in the treatment of moderate to severe hypertension. It is most frequently used in the treatment of severe hypertension that is resistant to other agents.
Guanethidine exerts its effects at peripheral sympathetic nerve endings following its active transport into the nerve varicosities by the neuronal amine transport system. This is the same uptake system that transports norepinephrine into the varicosity).The accumulation of guanethidine in adrenergic neurons, through an as yet unexplained mechanism, disrupts the process by which action potentials trigger the release of stored norepinephrine and other cotransmitters from nerve terminals. It is this action of guanethidine that is primarily responsible for its antihypertensive properties. Parasympathetic function is not altered, a fact that distinguishes guanethidine from the ganglionic blocking agent.
Guanethidine is suitable for oral use, and this is its usual route of administration. However, absorption from the gastrointestinal tract is variable. The half-life of guanethidine is 5 days, with about one-seventh of the total administered dose eliminated per day. The slow elimination contributes to the cumulative and prolonged effects of the drug.
Guanethidine reduces blood pressure by its ability to diminish vascular tone; both the arterial and venous sides of the circulatory system are involved. The resulting venous pooling contributes to orthostatic hypotension, a prominent feature of guanethidine treatment. The reduction in blood pressure is more prominent when the patient is standing than recumbent.

General Description

Guanethidine or guanethidinesulfate [C10H22N4·H2SO4].

Mechanism of action

Unlike adrenoblockers, guanethidine does not act on effector cells. It acts on branched ends of sympathetic peripheral nerve fibers and permeates into the neuron by the same mechanism of reverse uptake that returns norepinephrine from the synaptic cleft to neuron endings. Inside the neuron, guanethidine accumulates and competes with norepinephrine for storage space as granules. With an increase in guanethidine concentration, norepinephrine is replaced and thus the quantity of neurotransmitters capable of being released is reduced. In response to stimulation, the nerve may release guanethidine, which, however, is not an adrenergic receptor stimulant. In addition to this disturbance and the presence of stores of catecholamines in adrenergic nerve endings, guanethidine also acts on the stores of catecholamines in organs such as the heart, spleen, and aorta.Since it does not pass through the blood–brain barrier, it does not act on the central sympathetic neurons.

Side effects

Guanethidine may aggravate congestive heart failure or actually precipitate failure in patients with marginal cardiac reserve, owing to its ability to produce vascular volume expansion, edema, and a reduced effectiveness of sympathetic cardiac stimulation.
Guanethidine is contraindicated in patients with pheochromocytoma because the drug may release catecholamines from the tumor. The concomitant use of monoamine oxidase (MAO) inhibitors and guanethidine is also to be avoided, since this combined drug treatment eliminates two of the principal mechanisms for terminating the actions of the catecholamines and certain other adrenomimetic drugs, that is, biotransformation and neuronal uptake. Dangerously high concentrations of catecholamines at receptor sites are possible.

Synthesis

Guanethidine, |?-(1-azacyclooctyl)ethylguanidine (12.3.4), is synthesized in the following straightforward manner. Azocine is alkylated by chloracetonitrile, which forms 1-azocinylacetonitrile (12.3.2), which is reduced by lithium aluminum hydride into 1-(2-aminoethyl)azocine (12.3.3). Reacting this with S-methylthiourea gives guanethidine (12.3.4) [77¨C79].

Synthesis_55-65-2

guanethidine Preparation Products And Raw materials

Global( 11)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 9030 58 Inquiry
TargetMol Chemicals Inc. 4008200310 China 23963 58 Inquiry
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd 17691182729 18161915376 China 10011 58 Inquiry
3B Scientific Corporation 847.281.9822 United States 6744 47 Inquiry
2A PharmaChem USA (630) 737-0988 United States 6148 39 Inquiry
HONEST JOY HOLDINGS LIMITED +86-755-26404303 United States 6702 54 Inquiry
Waterstone Technology, LLC 317 644 0862 United States 6801 30 Inquiry
Lanospharma Laboratories Co.,Ltd 13440048448 China 6343 56 Inquiry
Leancare Ltd. +33 962096793 United Kingdom 6460 42 Inquiry
Changzhou Hopschain Chemical Co.,Ltd. 0519-85528066 13775048983 China 31557 55 Inquiry
1-(2-perhydroazocin-1-ylethyl)guanidine Octatensine Abapresin Dopom Eutensol N-[2-(Octahydroazocin-1-yl)ethyl]guanidine C07036 guanethidine 2-[2-(azocan-1-yl)ethyl]guanidine Guanidine, N-[2-(hexahydro-1(2H)-azocinyl)ethyl]- guanethidine USP/EP/BP Kynurenine Impurity 4 ((S)-4-Chloro Kynurenine) 55-65-2